✦ LIBER ✦

E5 Cost-effectiveness of first-line drugs for uncomplicated hypertension

✍ Scribed by K.A. Pearce; C.D. Furberg; B.M. Psaty; J.K. Kirk

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Identification of factors driving differ

✍ Scott W. Klarenbach; Finlay A. McAlister; Helen Johansen; Karen Tu; Maureen Haze 📂 Article 📅 2010 🏛 Pulsus Group Inc 🌐 English ⚖ 187 KB

Cochrane Database of Systematic Reviews

✍ Wright, James M 📂 Article 📅 2009 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 588 KB

PCN5: FIRST-LINE THERAPY FOR ADVANCED BR

✍ M Marchetti; N Liberato; G Barosi 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

Cost-effectiveness analysis of the first

✍ Jacques Cornuz; Christophe Pinget; Allison Gilbert; Fred Paccaud 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 622 KB

A Cost-Effectiveness Analysis of First-L

✍ Shih, Ya-Chen Tina; Mauskopf, Josephine; Borker, Rohit 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 161 KB

Cost-Effectiveness of Temsirolimus for F

✍ Martin Hoyle; Colin Green; Jo Thompson-Coon; Zulian Liu; Karen Welch; Tiffany Mo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB